Skip to content

Trial Illness Management and Recovery (IMR) Effects of IMR on patients with severe mental illness

Trial Illness Management and Recovery (IMR) Effects of IMR on patients with severe mental illness - Trial IMR

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39268
Enrollment
200
Registered
2012-08-27
Start date
2012-10-25
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Serious and Persistent Psychiatric Illness / Chronic Psychiatric Problems

Interventions

The IMR-training consists of 11 modules that are given weekly, the first module is given individually. During this individual module the patients decide which goals they want to work on during the p

Sponsors

Parnassia Bavo Groep (Den Haag)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with serious and persistent psychiatric illnesses. Most of them will be patients who have a psychotic disorder, schizoaffective disorders or bipolar disorders with or without comorbid disorders (such as substance abuse and personality disorders) - The patient is treated on an outpatient basis - Written informed consent

Exclusion criteria

Exclusion criteria: - Having done an IMR-training - Organic brain syndrome. - Incompetence regarding the giving of informed consent. - Patients with severe cognitive impairments who are unable to follow the training - Insufficient knowledge of the Dutch language (they can not participate in the group)

Design outcomes

Primary

MeasureTime frame
The illness management and recovery scale-patient self score version will be the primary outcome measure. This scale has 15 items and is completed by patients themselves. With this scale the effects of IMR in various domains can be measured (Mueser et al 2004; Salyers 2007; Hasson-Ohayon et al. 2008; Dutch translation De Vries 2011). The consumer and clinician versions of the Illness Management and Recovery (IMR) scales have adequate psychometric properties.

Secondary

MeasureTime frame
a Illness management - IMR-scale clinician-rated version This scale (15 items) will be used to explore effects. This scale is scored by non-blinded clinicians, who are not involved in the IMR-training. - Coping is measured with the Coping self-efficacy (CSES) scale (Chesney et al. 2006): *13-items*. This scale has good psychometric properties and provides according to the constructors a measure of a person*s perceived ability to cope effectively with life challenges, as well as a way to assess changes in CSE over time in intervention research. - Social support is measured with the Multidimensional Scale of Perceived Social Support MSPSS (Zimet, Dahlem, Zimet & Farley, 1988) (12 items) . This scale has good psychometric properties. - Medication compliance is measured with the Service Engagement Scale (SES) (Tait et al. 2002) (14-items). This scale has good psychometric properties. - Insight into own problems is measured with the Insight Scale (IS) (8 self-report items) (Birchwood et al, 1994). The psychometric properties of the scale are called excellent (Tait et al.2003). - Symptoms are measured with the Brief Symptom Inventory (BSI) (53 items) The authors report good internal consistency reliability, test-retest reliability and validity of the BSI. (Derogatis & Melisaratos 1983; Derogatis 1993; De Beurs, 2008). - Relapses: The number of relapses (operationalized in the number of hospital admissions) during and after participating in the IMR-training will be compared with the number of relapses in the year before participating in IMR. - Alcohol & Drugs-use: One item (item 24) of the Addiction Severity Index (ASI), asking how much respondents has been bothered the past 30 days by problems with a. alcohol, b. drugs, (a & b separately scored on a 5-point scale). b. Recovery The concept of recovery is complex. We choose to assess general recovery by using a special scale as well as measuring different aspects of recovery including aspects

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)